Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A–induced cytotoxicity
Wojciech Ornatowski, … , Jennifer L. Taylor-Cousar, Vojo Deretic
Wojciech Ornatowski, … , Jennifer L. Taylor-Cousar, Vojo Deretic
Published October 18, 2007
Citation Information: J Clin Invest. 2007;117(11):3489-3497. https://doi.org/10.1172/JCI31499.
View: Text | PDF
Research Article Cell biology

Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A–induced cytotoxicity

  • Text
  • PDF
Abstract

Progressive pulmonary disease and infections with Pseudomonas aeruginosa remain an intractable problem in cystic fibrosis (CF). At the cellular level, CF is characterized by organellar hyperacidification, which results in altered protein and lipid glycosylation. Altered pH of the trans-Golgi network (TGN) may further disrupt the protein processing and packaging that occurs in this organelle. Here we measured activity of the major TGN endoprotease furin and demonstrated a marked upregulation in human CF cells. Increased furin activity was linked to elevated production in CF of the immunosuppressive and tissue remodeling cytokine TGF-β and its downstream effects, including macrophage deactivation and augmented collagen secretion by epithelial cells. As furin is responsible for the proteolytic processing of a range of endogenous and exogenous substrates including growth factors and bacterial toxins, we determined that elevated furin-dependent activation of exotoxin A caused increased cell death in CF respiratory epithelial cells compared with genetically matched CF transmembrane conductance regulator–corrected cells. Thus elevated furin levels in CF respiratory epithelial cells contributes to bacterial toxin–induced cell death, fibrosis, and local immunosuppression. These data suggest that the use of furin inhibitors may represent a strategy for pharmacotherapy in CF.

Authors

Wojciech Ornatowski, Jens F. Poschet, Elizabeth Perkett, Jennifer L. Taylor-Cousar, Vojo Deretic

×

Figure 1

Furin levels are elevated in CF cells.

Options: View larger image (or click on image) Download as PowerPoint
Furin levels are elevated in CF cells.
Furin activity was measured by mo...
Furin activity was measured by monitoring cleavage of fluorogenic substrate boc-RVRR-amc in extracts from lung epithelial cells. One unit of activity was defined as the amount of enzyme required to liberate 1 pmol of AMC from boc-RVRR-amc. (A) IB3-1, pCEP-R, and CFBE (all 3 cell lines with a CF phenotype) and S9, pCEP, and 16HBE (all 3 cell lines with CFTR-corrected or non-CF phenotype). (B) Furin activity in primary human (CF and normal) lung epithelial cells measured in the presence or absence of the furin inhibitor CMK. (C) Furin western blot and densitometry analysis. (D) Human lung epithelial cells after treatment with furin inhibitors CMK and α1-PDX. Production of TGF-β was measured in IB3-1 (CF) and S9 (CFTR corrected) epithelial cells using TGF-β–responsive luciferase assay. CMK, 50 μM; α1-PDX, 5 μM. Data are presented as percentage of furin or TGF-β, for which 100% corresponds to protein levels in non-CF cells (n = 3 experiments). Mean ± SEM (*P < 0.05, **P < 0.01; †P ≥ 0.05).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts